- Nachrichtendetail
-
12.02.2024 15:11:27 - dpa-AFX: AstraZeneca Invests $300 Mln In Cell Therapy Facility At Alexandria Centre For Life Science
WASHINGTON (dpa-AFX) - Alexandria Real Estate Equities, Inc. (ARE) announced
on Monday that its long-term tenant AstraZeneca PLC (AZN) has planned to invest
$300 million in a next-generation cell therapy manufacturing facility at the
Alexandria Centre for Life Science in Rockville, Maryland, which will create
more than 150 highly skilled job opportunities.
The real estate company stated that AstraZeneca expects the facility to support
the biomanufacturing of T-cell therapies for clinical trials and commercial
purposes.
In the pre-market activity, Alexandria's stock is trading at $116.22, up 0.02
percent on the New York Stock Exchange.
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
on Monday that its long-term tenant AstraZeneca PLC (AZN) has planned to invest
$300 million in a next-generation cell therapy manufacturing facility at the
Alexandria Centre for Life Science in Rockville, Maryland, which will create
more than 150 highly skilled job opportunities.
The real estate company stated that AstraZeneca expects the facility to support
the biomanufacturing of T-cell therapies for clinical trials and commercial
purposes.
In the pre-market activity, Alexandria's stock is trading at $116.22, up 0.02
percent on the New York Stock Exchange.
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
ALEXANDRIA REAL EST. EQU. | 907179 | Frankfurt | 113,200 | 17.05.24 15:29:01 | -0,900 | -0,79% | 0,000 | 0,000 | 113,600 | 113,200 |
